Raras
Buscar doenças, sintomas, genes...
Uveíte intermédia
ORPHA:279914CID-10 · H30.2CID-11 · 9B66DOENÇA RARA

Inflamação da parte plana do olho.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Inflamação da parte plana do olho.

Pesquisas ativas
2 ensaios
64 total registrados no ClinicalTrials.gov
Publicações científicas
1.042 artigos
Último publicado: 2026 Apr 17

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H30.2
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
8 sintomas
🛡️
Imunológico
1 sintomas
🧬
Pele e cabelo
1 sintomas
🫘
Rins
1 sintomas

+ 7 sintomas em outras categorias

Características mais comuns

55%prev.
Edema macular
Frequente (79-30%)
17%prev.
Membrana epirretiniana
Ocasional (29-5%)
17%prev.
Uveíte anterior
Ocasional (29-5%)
17%prev.
Glaucoma
Ocasional (29-5%)
17%prev.
Catarata
Ocasional (29-5%)
17%prev.
Moscas volantes
Ocasional (29-5%)
18sintomas
Frequente (1)
Ocasional (13)
Muito raro (4)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 18 características clínicas mais associadas, ordenadas por frequência.

Edema macularMacular edema
Frequente (79-30%)55%
Membrana epirretinianaEpiretinal membrane
Ocasional (29-5%)17%
Uveíte anteriorAnterior uveitis
Ocasional (29-5%)17%
Glaucoma
Ocasional (29-5%)17%
CatarataCataract
Ocasional (29-5%)17%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.042PubMed
Últimos 10 anos200publicações
Pico202588 papers
Linha do tempo
2026Hoje · 2026🧪 1995Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado4
3Fase 37
2Fase 26
·Pré-clínico3
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Uveíte intermédia

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

64 ensaios clínicos encontrados, 2 ativos.

Distribuição por fase
NCT06431373 · A Study of Brepocitinib in Adults With Active, Non-Infectiou…Ativo
PHASE3
NCT02931175 · ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)Concluído
PHASE2
NCT05523765 · A Study of Brepocitinib in Adults With Active Non-Infectious…Concluído
PHASE2
NCT03816397 · Adalimumab in JIA-associated Uveitis Stopping TrialConcluído
PHASE4
NCT05101928 · Ozurdex Monotherapy TrialCancelado
PHASE4
NCT05384249 · Phase 2b Pivotal Study of Izokibep in Non-infectious, Interm…Encerrado
PHASE2
NCT05070728 · Safety and Efficacy of an Injectable Fluocinolone Acetonide …Encerrado
PHASE3
NCT00331331 · The Vitreous Proteome and Inflammatory Mediators in Ocular I…Concluído
NCT05953688 · POC Study to Evaluate the Efficacy and Safety of ESK-001 in …Encerrado
PHASE2
NCT00499551 · A Phase I/IIa Study for the Treatment of Uveitis With Iontop…Cancelado
PHASE1, PHASE2
NCT01280669 · Intravitreal Sirolimus as Therapeutic Approach to UveitisCancelado
PHASE2
NCT06085079 · Ixekizumab for the Management of Refractory Non-Infectious U…UNKNOWN
PHASE4
NCT00539370 · Human Samples and Data RepositoryEncerrado
NCT03656692 · Safety and Effectiveness of Acthar Gel for Inflammation of t…Encerrado
PHASE4
NCT01148225 · A Study of the Long-term Safety and Efficacy of Adalimumab i…Concluído
PHASE3
NCT01124838 · Efficacy and Safety of Adalimumab in Subjects With Inactive …Concluído
PHASE3
NCT01138657 · Efficacy and Safety of Adalimumab in Patients With Active Uv…Concluído
PHASE3
NCT03097315 · Suprachoroidal Injection of CLS-TA in Patients With Non-infe…Concluído
PHASE3
NCT02952001 · MAGNOLIA: Extension Study of Patients With Non-infectious Uv…Concluído
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
586 papers (10 anos)
#1

The Association Between Uveitis and Optic Neuritis in Central Nervous System Demyelinating Disorders: A Multi-Institutional Cohort Study.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society2026 Mar 24

Uveitis and optic neuritis related to demyelinating disease share similar immune mechanisms and can have deleterious visual consequences. Data on uveitis incidence in patients with central nervous system (CNS) demyelinating diseases remain limited. Our objective was to assess the 5-year incidence of uveitis among patients with CNS demyelinating diseases with and without optic neuritis. Retrospective cohort study using a health records aggregate. We identified patients aged ≥18 years using diagnostic codes to arrange into 3 study groups: a composite CNS demyelinating disease cohort, a multiple sclerosis (MS) cohort, and a neuromyelitis optica/myelin oligodendrocyte glycoprotein antibody-associated disease cohort, each stratified by presence or absence of optic neuritis. We matched each study group based on demographics, clinical comorbidities, medications, and encounter visits. After matching, the 5-year cumulative incidence of any uveitis among patients with optic neuritis in the CNS demyelinating disease group was 1.09% (95% confidence intervals [CI] 0.950-1.25) compared with 0.610% (95% CI 0.501-0.743) in those without optic neuritis (log-rank P < 0.0001), with a hazard ratio (HR) of 1.99 (95% CI 1.57-2.52). The 5-year cumulative incidence of any uveitis among patients with optic neuritis in patients with MS was 0.986% (95% CI 0.846-1.15) compared to 0.543% (95% CI 0.437-0.676) in those without optic neuritis (log-rank P < 0.0001), with a HR of 1.95 (95% CI 1.51-2.53). Although patients with neuromyelitis optica/myelin oligodendrocyte glycoprotein antibody-associated disease showed similar trends, there was no statistical significance. Intermediate uveitis demonstrated the strongest associations with optic neuritis across study groups. Optic neuritis is a clinically meaningful risk factor for uveitis in patients with CNS demyelinating disease, underscoring the need for careful ophthalmic surveillance in this population.

#2

Long-Term Follow Up of Presumed Trematode Induced Granulomatous Intermediate Uveitis: Predictors for Failure of Medical Treatment.

Ocular immunology and inflammation2026 Mar 23

To identify predicators of medical treatment failure in patients with presumed trematode induced granulomatous intermediate uveitis (PTIGIU). A retrospective review of the medical records of children diagnosed with PTIGIU over a 4-year period was conducted. Main outcome measures included the management options and treatment outcomes. 98 eyes of 90 patients clinically diagnosed with PTIGIU were initially reviewed with a minimum follow up of 2 years. Mean age was 11 ± 2.38 years and 96.9% were males. All patients reported a history of freshwater exposure with a mean exposure to presentation time of 3 ± 2.822 weeks. UBM detected CB granuloma and confirmed the diagnosis in 53 eyes, 27 of which had an associated AC granuloma. Management options included surgical intervention in the form of parsplana vitrectomy ± lensectomy, or conservative management with systemic, topical or periocular steroids. Surgical interventions were done in 30 eyes, 20 of which had initially received conservative management that subsequently failed and required surgery. Univariate logistic regression revealed that CDVA, degree of vitreous/AC inflammation and lens status at initial presentation were significant predictors for surgical intervention (p < 0.001, 0.008, 0.005 and <0.001 respectively). CDVA, vitritis and degree of AC inflammation were also associated with failure of initial conservative management (p = 0.008, 0.005 and 0.009 respectively). Various management options exist for patients with PTIGIU, but patients with lower presenting vision and higher degrees of vitreous inflammation respond better to surgical intervention than medical therapy alone.

#3

Relapsing Intermediate Uveitis following Resolved Syphilitic Retinitis in an HIV-Positive Patient: A Case Report.

Case reports in ophthalmology2026

Ocular syphilis has atypical presentation in immunocompromised individuals. We report a case of intermediate uveitis as a delayed immune-mediated relapse following the successful treatment of syphilitic retinitis in an HIV-positive individual. A 30-year-old HIV-positive man presented with decreased vision in his left eye. Examination revealed left eye granulomatous anterior uveitis with vitritis, retinal vasculitis, and optic disc edema. The patient was diagnosed with syphilitic uveitis, reactive for rapid plasma reagin (RPR), and initiated on intravenous penicillin by the internist. Topical corticosteroids were initiated, and oral corticosteroids were added after 1 week. Over 2 months, the lesions resolved clinically with decreasing RPR titers. After 2 months of complete remission and tapering of therapy, the patient presented with renewed disc edema, macular edema, vitreous cells, and snowballs suggestive of intermediate uveitis. The RPR titers showed a decreasing pattern. The patient responded well to oral corticosteroids, indicating a likely immune-mediated relapse rather than reinfection. This case highlights the need for continued surveillance, even after clinical resolution.

#4

Pattern of Uveitis in a Secondary Eye Care Center at Panipat, Haryana.

Clinical ophthalmology (Auckland, N.Z.)2026

Uveitis pattern varies according to regional, demographic, and racial factors. Therefore, an epidemiological study of the distribution of uveitis in various regions in India is likely to provide valuable information. There is no study available on the pattern of uveitis from Haryana. To report the pattern of uveitis in a secondary eye care center in Panipat, Haryana. A retrospective study was conducted on 65,126 new patients who attended the Ophthalmology outpatient department of a secondary eye care hospital in Panipat from April 2015 to October 2023. The data of all the subjects is taken from electronic medical records analyzed. Minimum age of the patients was 8 years, the maximum was 95 years and the mean age was 42.28 years. Out of 65,126 cases, 377 were found to have uveitis. The cumulative incidence proportion of uveitis among new patients attending our institute during the study period was 0.58%. The majority of patients were of anterior uveitis 158 (41.8%) and the minimum belonged to intermediate uveitis 39 (10.3%). It was also seen that the maximum cases were unilateral. Tailored laboratory investigations were done in all the cases. The most common cause was found to be idiopathic. Anterior uveitis is the most common entity in secondary care and the most common etiology found to be idiopathic.

#5

An Atypical Presentation of Tubulointerstitial Nephritis With Uveitis (TINU) in an Older Patient Requiring Emergency Dialysis: A Case Report.

Clinical case reports2026 Feb

Tubulointerstitial nephritis with uveitis (TINU) is an immune-mediated systemic disorder most commonly described in adolescents and young adults, and its recognition in older patients remains challenging. We report the case of a 58-year-old woman who presented with systemic symptoms and rapidly progressive acute kidney injury. Renal function deteriorated significantly, necessitating emergency hemodialysis. Renal biopsy demonstrated acute tubulointerstitial nephritis with diffuse interstitial inflammation and minimal fibrosis. During hospitalization, ocular symptoms were identified, and a comprehensive ophthalmologic examination confirmed intermediate uveitis, establishing the diagnosis of TINU syndrome. Treatment with standard-dose corticosteroid therapy resulted in rapid clinical improvement, recovery of urine output, and discontinuation of dialysis within a short period. Renal function and ocular inflammation improved in parallel. Corticosteroids were gradually tapered without relapse. At long-term outpatient follow-up on September 15, 2025, the patient remained clinically stable, with serum creatinine levels ranging from 60 to 70 μmol/L and no recurrence of uveitis. This case highlights an atypical presentation of TINU in an older patient complicated by severe acute kidney injury requiring dialysis and underscores the importance of considering TINU in patients with unexplained acute kidney injury and ocular manifestations, regardless of age. Early recognition and appropriate immunosuppressive therapy are essential for favorable renal and ocular outcomes.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC321 artigos no totalmostrando 196

2026

The Association Between Uveitis and Optic Neuritis in Central Nervous System Demyelinating Disorders: A Multi-Institutional Cohort Study.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
2026

Long-Term Follow Up of Presumed Trematode Induced Granulomatous Intermediate Uveitis: Predictors for Failure of Medical Treatment.

Ocular immunology and inflammation
2026

Relapsing Intermediate Uveitis following Resolved Syphilitic Retinitis in an HIV-Positive Patient: A Case Report.

Case reports in ophthalmology
2026

Pattern of Uveitis in a Secondary Eye Care Center at Panipat, Haryana.

Clinical ophthalmology (Auckland, N.Z.)
2026

An Atypical Presentation of Tubulointerstitial Nephritis With Uveitis (TINU) in an Older Patient Requiring Emergency Dialysis: A Case Report.

Clinical case reports
2026

Retrospective Case Series of Ocular Lyme Disease, 1988-2025.

Emerging infectious diseases
2026

Comparison of pediatric patients with pars planitis who underwent treatment versus observation at a tertiary referral eye center.

Retina (Philadelphia, Pa.)
2026

Ocular findings in patients with lyme disease: a systematic review and meta-analysis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Retinal Detachment Associated with Presumed Trematode-Induced Granulomatous Intermediate Uveitis.

Retina (Philadelphia, Pa.)
2025

Bilateral acute intermediate uveitis following intrauterine Chitosan tamponade: a case series.

Journal of ophthalmic inflammation and infection
2026

Presumed Trematode-Induced Ciliary Body Granuloma; Clinical Patterns and Management.

Ocular immunology and inflammation
2025

Etiologies of intermediate uveitis in a tertiary center: an age-oriented medical assessment?

Journal of ophthalmic inflammation and infection
2025

Use of brolucizumab in refractory neovascular age-related macular degeneration: characteristics and biomarkers of intraocular inflammation from an Asian real-world study.

Japanese journal of ophthalmology
2025

Implications of peripapillary retinal nerve fiber layer thickening by optical coherence tomography in children with pars planitis.

Journal of ophthalmic inflammation and infection
2025

Intraocular inflammation following aflibercept 8 mg: real-world data from a multicentre retrospective observational study.

International journal of retina and vitreous
2025

Neuromyelitis Optica-Associated Acute Intermediate Uveitis.

International medical case reports journal
2025

Suprachoroidal Triamcinolone Acetonide for the Treatment of Refractory Macular Edema Secondary to Non-Infectious Uveitis.

Research square
2026

Presumed Ocular Tuberculosis: Insights from an Egyptian Cohort.

Ocular immunology and inflammation
2025

Multiple sclerosis-associated uveitis successfully controlled with ofatumumab.

Journal of ophthalmic inflammation and infection
2025

Characteristics and complications of uveitis in patients referred to rheumatology: a single-center study.

Turkish journal of medical sciences
2025

Immunotherapy and Direct Acting Anti-Cancer Agent Associated-Uveitis.

Ocular immunology and inflammation
2025

Repository Corticotropin Therapy for Refractory Noninfectious Inflammatory Ocular Diseases.

Journal of clinical medicine
2025

Ebstein-Bar Virus (EBV)-Positive diffuse large B-cell vitreoretinal lymphoma: Two cases without overt immunocompromise and review of the literature.

American journal of ophthalmology case reports
2025

Circulating CD16-Positive Monocyte-like Myeloid-Derived Suppressor Cells and Intermediate Monocytes Associated with Clinical and Immunological Complications in Pars Planitis Patients.

Cells
2025

Fuchs uveitis: A clinical analysis of 339 patients from India.

Indian journal of ophthalmology
2025

Adalimumab in non-infectious uveitis, towards a real-world therapeutic paradigm beyond inflammation control: A multicenter cross-sectional study.

Journal of ophthalmic inflammation and infection
2026

Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial.

Ophthalmology
2025

Analysis of Clinical Characteristics and Posterior Segment Parameters in Multiple Sclerosis-Associated Uveitis with Optical Coherence Tomography Angiography.

Ocular immunology and inflammation
2025

Scleral Rupture with Uveal Prolapse Following Trivial Trauma in an Eye Previously Treated with Internal and External Cyclodestructive Procedures: A Case Report.

The American journal of case reports
2025

Partial Response to Abatacept for Bilateral Asymmetrical Intermediate Uveitis in CTLA-4 Haploinsufficiency.

Ocular immunology and inflammation
2025

Specific Skin Lesions of Sarcoidosis in the Diagnosis of Ocular Sarcoidosis.

Ocular immunology and inflammation
2025

Acute Posterior Multifocal Placoid Pigment Epitheliopathy-Like Panuveitis Following Mpox Vaccination.

Ocular immunology and inflammation
2025

Prevalence and Prognosis of Glaucoma/Elevated Intraocular Pressure in Patients with Uveitis.

Turkish journal of ophthalmology
2025

The causal relationship between uveitis and psoriatic arthritis: A bidirectional Mendelian randomisation study.

Indian journal of dermatology, venereology and leprology
2025

Demographic and Clinical Characteristics of Pediatric Uveitis Cases from a Referral Center in Turkey.

Ocular immunology and inflammation
2025

A rare cause of visual impairment in patients with multiple sclerosis: Uveitis.

Journal of neuroimmunology
2025

Bilateral acute retinal necrosis after ofatumumab masquerading as intermediate uveitis in a patient with multiple sclerosis.

American journal of ophthalmology case reports
2025

Epidemiology and Clinical Features of Uveitis in Southwestern Japan: Laterality and Long-Term Visual Prognosis Based on the Anatomical and Epidemiological Classification.

Ocular immunology and inflammation
2025

Clinical features, treatment and outcomes of dabrafenib-associated uveitis.

Investigational new drugs
2025

Successful Use of Upadacitinib, a Selective JAK Inhibitor, in the Treatment of Two Cases of Recalcitrant Chronic Uveitis.

Journal of ophthalmic &amp; vision research
2025

Specific retinal vasculitis in HLA-A29 birdshot retinochoroiditis, distinguishing it from other causes of vasculitis: A pilot study.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2025

Ocular inflammation as the first presenting feature of PRF1-associated familial hemophagocytic lymphohistiocytosis, case report and review of literature.

BMC ophthalmology
2025

Pediatric Noninfectious Intermediate, Posterior, and Panuveitis: A Review.

International ophthalmology clinics
2025

Treatment of ocular sarcoidosis. Study of 65 patients from a series of 342 from a university hospital in northern Spain.

International ophthalmology
2025

Etiology and Anatomical Location of Uveitis-Prognostic Factors for Disease Course and Laterality.

Life (Basel, Switzerland)
2025

Expanding the knowledge about Thauvin-Robinet-Faivre syndrome: a case report with novel clinical findings and review of the literature.

Journal of applied genetics
2025

Intraocular inflammation following intravitreal injections of anti-vascular endothelial growth factor drugs.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2025

Intravitreous Metastatic Cutaneous Melanoma Mimicking Intermediate Uveitis.

Ophthalmology
2025

Incidence and Prevalence of Glaucoma, Corticosteroid Response, and Ocular Hypertension in Uveitis and its Anatomical Subtypes.

American journal of ophthalmology
2025

Pharmacotherapy for non-infectious uveitis: spotlight on phase III clinical trials of locally injected or implanted therapeutics and systemic immunomodulatory drugs.

Journal of ophthalmic inflammation and infection
2024

Magic of Intravitreal Triamcinolone and Dexamethasone in a Patient with Uveitic Macular Edema with Treated Ocular Tuberculosis.

Kathmandu University medical journal (KUMJ)
2025

Infectious uveitis: Epidemiology, etiology, diagnostic test performance and treatment.

Archivos de la Sociedad Espanola de Oftalmologia
2025

Physician Burden and Time Delays in Initiating Immunomodulatory Therapy for Noninfectious Uveitis and Inflammatory Eye Diseases.

American journal of ophthalmology
2025

Uveitis in Adults: A Review.

JAMA
2025

A rare large-vessel involvement in a patient with a clinical diagnosis of granulomatosis with polyangiitis: A case report.

Modern rheumatology case reports
2025

Comparative Effectiveness of Intravenous versus Subcutaneous Tocilizumab for Refractory Uveitis: A Retrospective Analysis.

Ophthalmology
2025

Clinical characteristics and outcomes of pediatric anterior and intermediate uveitis in China.

Molecular immunology
2025

Fern-Like Retinal Vasculopathy in Intermediate Uveitis: Pathogenesis, Natural History, and Clinical Implications.

American journal of ophthalmology
2025

Treatment outcomes of a Swiss non-infectious paediatric uveitis cohort: retrospective study over ten years.

Journal of ophthalmic inflammation and infection
2025

Fern-Like Pattern on Ultra-Widefield Fluorescein Angiography Across Various Uveitic Conditions.

Romanian journal of ophthalmology
2025

Disease of the Year 2024: Intermediate Uveitis.

Ocular immunology and inflammation
2025

Programme for ocular inflammation & infection translational research (PROTON) registry: Cross-sectional analysis of baseline patient characteristics.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2025

Comprehensive Update on Multiple Sclerosis-Associated Uveitis and New Epidemiological Insights from the United Kingdom.

Ocular immunology and inflammation
2025

Epidemiology of Uveitis from a Tertiary Referral Hospital in Bulgaria over a 13-Year Period.

Diagnostics (Basel, Switzerland)
2025

Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.

Journal for immunotherapy of cancer
2025

Central Nervous System Demyelination in Paediatric Pars Planitis.

Ocular immunology and inflammation
2025

Cumulative incidence of macular edema in non-infectious uveitis indicates an early therapeutic window.

Acta ophthalmologica
2025

Inherited retinal disease-associated uveitis.

Survey of ophthalmology
2025

Approach and surgical management of epiretinal membrane.

Current opinion in ophthalmology
2025

[Ten-year study of the epidemiology and clinical features of uveitis in Picardie, France].

Journal francais d'ophtalmologie
2025

[A NEW MULTIPLE SCLEROSIS DIAGNOSIS IN A PATIENT WITH INTERMEDIATE UVEITIS].

Harefuah
2025

Case report: Effectiveness of Janus kinase inhibitors in the management of isolated noninfectious uveitis: a case series.

Frontiers in pharmacology
2025

Bilateral spontaneous retinal dialysis in multiple sclerosis related intermediate uveitis: Unusual case report.

American journal of ophthalmology case reports
2025

A Case of Sarcoid Uveitis Diagnosed With Mammography Two Months After Normal Chest Imaging.

Case reports in ophthalmological medicine
2025

Unusual Manifestation of Bilateral Intermediate Uveitis Caused by Ocular Cytomegalovirus (CMV) in Immunocompetent Individual.

Cureus
2025

Clinical Features, Complications, and Treatment Outcomes of Pediatric Pars Planitis Cases in a Tertiary Referral Center.

Ocular immunology and inflammation
2025

Symptomatic Occlusive Retinal Vasculitis as an Unusual Presentation of Biopsy-Proven Sarcoidosis: A Case Series.

Ocular immunology and inflammation
2025

Vitreous hemorrhage in patients with uveitis: a comparative study between adults and children.

International ophthalmology
2025

Clinical characteristics, treatment, and outcomes of nivolumab-induced uveitis.

Immunopharmacology and immunotoxicology
2025

Prospective International Registry for Treatment Exit Options in Uveitis (TOFU) - the First Five Years.

Klinische Monatsblatter fur Augenheilkunde
2025

Intermediate Uveitis: An Updated Review of the Differential Diagnosis and Relevant Special Investigations.

Ocular immunology and inflammation
2026

Intraocular Metastatic Lung Adenocarcinoma Masquerading as an Intermediate Uveitis.

Ocular immunology and inflammation
2025

Demographic Features, Diagnoses and Real-World Clinical Management of Uveitis in Japan.

Ocular immunology and inflammation
2025

Detection of Mycobacterium tuberculosis DNA in intraocular fluid of 11 suspected tuberculous uveitis patients by multiplex PCR.

BMC ophthalmology
2024

The Efficacy of Adalimumab Treatment in Pediatric Non-Infectious Uveitis: A Retrospective Cohort Study.

Turkish journal of ophthalmology
2025

Pattern of Uveitis in Northern Vietnam.

Ocular immunology and inflammation
2024

Targeting alpha-4 integrin with natalizumab for intermediate uveitis associated with multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical
2025

Patterns and Outcomes of Pediatric Uveitis in a University-Based Tertiary Referral Center in Riyadh, Saudi Arabia.

Ocular immunology and inflammation
2024

Progressive Uveitis as a Diagnostic and Therapeutic Challenge in Whipple's Disease.

Cureus
2025

Bilateral Involvement in Childhood Presumed Trematode Induced Granulomatous Anterior Uveitis.

Ocular immunology and inflammation
2025

Clinical Profiles of Retinal Vasoproliferative Tumors.

Journal of vitreoretinal diseases
2024

Diagnostic Dilemma: Ocular Features and Treatment Outcome of a Case of Coats-Like Retinitis Pigmentosa.

Cureus
2025

Uveitis among people with multiple sclerosis: A systematic review and meta-analysis.

Survey of ophthalmology
2024

Gaucher disease type 3c: Expanding the clinical spectrum of an ultra-rare disease.

JIMD reports
2025

Three-Year Results of XEN-45 Implantation for Glaucoma Secondary to Fuchs Uveitis Syndrome, Intermediate Uveitis, and Juvenile Idiopathic Arthritis-Related Anterior Uveitis.

Ocular immunology and inflammation
2025

Adalimumab-induced CNS demyelination in a patient with multiple pre-existing autoimmune diseases: Treatment contemplation.

Modern rheumatology case reports
2025

Long-Term Outcomes of Pediatric Pars Planitis: Retrospective Cohort from a Single Tertiary Center in Turkey.

Ocular immunology and inflammation
2024

Multiple sclerosis-associated uveitis in Persian population, a multicenter study.

Multiple sclerosis and related disorders
2024

Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: A systematic review and meta-analysis.

PloS one
2025

Brain MRI White Matter Abnormalities in Pediatric Non-Infectious Uveitis.

Ocular immunology and inflammation
2024

Epithelial downgrowth masquerading as granulomatous anterior and intermediate uveitis with histopathologic evidence of 5-FU treatment.

GMS ophthalmology cases
2025

Epidemiology of Intermediate Uveitis.

Ocular immunology and inflammation
2024

Ibrutinib-Related Uveitis in Non-Hodgkin Lymphoma Patients: A Case Report and Literature Review.

Ocular immunology and inflammation
2025

Review for Disease of the Year Clinical Features and Ocular Imaging in Intermediate Uveitis and Pars Planitis.

Ocular immunology and inflammation
2024

Insights into uveitis from Brentuximab vedotin in refractory Hodgkin's lymphoma: a case report and brief review.

Frontiers in oncology
2024

Clinical Profile and Ocular Morbidities in Patients with Both Diabetic Retinopathy and Uveitis.

Ophthalmology science
2025

Severe Intraocular Inflammation After Intravitreal Injection of Faricimab: A Single-Site Case Series of Six Patients.

American journal of ophthalmology
2025

Anterior and intermediate uveitis with macular hole probably secondary to high-voltage electrical burn.

Clinical &amp; experimental optometry
2024

Presentation of Adult-onset Asthma and Periocular Xanthogranuloma with Intermediate Uveitis and Hodgkin's Lymphoma: A Case Report.

Journal of ophthalmic &amp; vision research
2024

[Uveitis and multiple sclerosis : Clinical aspects, diagnostics, management and treatment].

Die Ophthalmologie
2024

Intermediate uveitis in common variable immunodeficiency (CVID) associated with a heterozygous variant in the TNFRSF13B gene.

Retinal cases &amp; brief reports
2025

Ocular Complications of Intermediate Uveitis.

Ocular immunology and inflammation
2024

Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical Trial.

JAMA ophthalmology
2025

The Spectrum of Presumed Tubercular Uveitis in a Referral Eye Clinic in Qatar.

Ocular immunology and inflammation
2024

Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uveitic Glaucoma.

Ophthalmology and therapy
2024

Dysregulated Th17/Treg cell axis is correlated with local and systemic immune response in human intermediate uveitis.

Immunology letters
2024

Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis.

BMC ophthalmology
2024

Treatment exit options for non-infectious uveitis registry: participant characteristics at 3 years.

The British journal of ophthalmology
2024

Manifestations and Management of Inflammatory Eye Disease in Patients with Inflammatory Bowel Disease.

Ocular immunology and inflammation
2024

A case report of pediatric-onset MS associated uveitis.

Journal of ophthalmic inflammation and infection
2024

Uveitis Profile in Children and Its Impact on Vision at Queen Rania Children's Hospital.

Cureus
2024

Tattoo-Induced Exacerbations of Systemic Disease and Uveitis.

Journal of vitreoretinal diseases
2024

Aqueous humor perturbations in chronic smokers: a proteomic study.

Scientific reports
2024

Treatment of uveitis and scleritis patients in Malaysia.

International journal of ophthalmology
2025

Intermediate Uveitis with Cystoid Macular Edema as Presentation of Retained Caterpillar Hair in the Vitreous Cavity.

Ocular immunology and inflammation
2024

Clinical features, diagnosis, treatment, and course of ocular sarcoidosis with or without uveitis: A retrospective, comparative study.

Journal francais d'ophtalmologie
2024

Prevalence, clinical characteristics, and independent predictors of uveitic macular edema in an Asian population: a retrospective cohort study.

BMC ophthalmology
2025

Anterior Vitreous Objective Assessment in Uveitis: An Anterior Segment Swept Source Optical Coherence Tomography Study.

Ocular immunology and inflammation
2024

Ophthalmological and Neurological Findings in Patients with Idiopathic Uveitis Associated with Retinal Vasculitis and the Relation with the HLA DR15 Allele.

Ocular immunology and inflammation
2024

Vitiligo in a Patient Receiving Adalimumab for Idiopathic Uveitis.

Turkish journal of ophthalmology
2024

Vasoproliferative Tumor Secondary to Sarcoidosis-Associated Intermediate Uveitis.

Turkish journal of ophthalmology
2024

Epidemiological, Clinical, and Therapeutic Profile of Uveitis in Multiple Sclerosis: A Multicenter Study.

Ocular immunology and inflammation
2024

New onset of uveitis during infliximab treatment: A case report.

La Tunisie medicale
2024

Association of Fuchs Heterochromic Iridocyclitis with Multiple Sclerosis.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti
2024

Ultrawide-field fluorescein angiography features in patients with anterior uveitis.

Eye (London, England)
2024

An Analysis of the clinical and investigative profile of uveitis in the elderly: First case series from India.

Indian journal of ophthalmology
2024

Epidemiology, clinical features, and classification of 3,404 patients with uveitis: Colombian Uveitis Multicenter Study (COL-UVEA).

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2024

Systemic and Ocular Manifestations of Arboviral Infections: A Review.

Ocular immunology and inflammation
2024

Evaluation of Optical Coherence Tomography Angiography Findings in Pars Planitis and Multiple Sclerosis Associated Intermediate Uveitis in Remission.

Current eye research
2024

Retinal Vasoproliferative Tumours in Uveitis.

Ocular immunology and inflammation
2024

Uveitis Onset and Flare-Up: Does the Time of Year Matter?

Ocular immunology and inflammation
2023

Clinical and therapeutic characteristics of childhood uveitis in a tertiary center in Tunisia.

La Tunisie medicale
2024

Anterior-Segment Optical Coherence Tomography Unlocks Novel Perspectives: Lacking Iris Anterior Limiting Layer Signal in Uveitis.

Cureus
2024

Evolving Fuchs' uveitis - A diagnostic challenge.

Indian journal of ophthalmology
2024

Vessel density on optical coherence tomography angiography is prognostic for future disease course in intermediate uveitis.

Scientific reports
2024

Multiple sclerosis-associated uveitis - A series from South India.

Indian journal of ophthalmology
2024

Epiretinal membrane in uveitis: Rate, visual prognosis, complications and surgical outcomes.

Clinical &amp; experimental ophthalmology
2023

First contact investigations and compliance to treatment in patients with uveitis.

International journal of ophthalmology
2023

Pediatric Pars Planitis: A Review.

Ocular immunology and inflammation
2023

Epidemiology of Pediatric Uveitis.

Ocular immunology and inflammation
2024

Ocular Whipple Disease: Cases Diagnosed Over Four Decades.

Ocular immunology and inflammation
2023

Effects of Subcutaneous Methotrexate in Patients with Refractory Uveitis and Chorioretinitis.

Korean journal of ophthalmology : KJO
2023

Evaluation of the structural changes of uveitis patients by optical biometry.

Romanian journal of ophthalmology
2023

SER recommendations for the treatment of uveitis.

Reumatologia clinica
2023

Involvement of the systemic microcirculation in pediatric uveitis.

Pediatric rheumatology online journal
2023

Capsular phimosis with intraocular lens tilt and decentration.

Journal of cataract and refractive surgery
2023

Treatment of Intermediate Uveitis-associated Retinal Vasoproliferative Tumors: A Case Series.

Retinal cases &amp; brief reports
2023

Analysis of HLA Profiles in 390 Uveitis Cases: Insights into Clinical Presentations.

Alternative therapies in health and medicine
2023

Prognostic factors of cataract surgery in patients with uveitis.

International ophthalmology
2023

Clinical features of infectious uveitis in a Tunisian population.

La Tunisie medicale
2024

Effects of non-medical infliximab biosimilar switching in ocular inflammatory diseases: A case series from a tertiary care center.

European journal of ophthalmology
2023

Corticosteroid implants for chronic non-infectious uveitis.

The Cochrane database of systematic reviews
2023

Prevalence and characteristics of HTLV-associated uveitis in patients from Bahia, an endemic area for HTLV - 1 in Brazil.

Virology journal
2024

Characterization of autoimmune eye disease in association with Down's syndrome.

Eye (London, England)
2024

Non-infectious uveitis referred for pediatric rheumatologic assessment and management: A Portuguese retrospective study.

Modern rheumatology
2023

[Research progress of optical coherence tomography and optical coherence tomography angiography in noninfectious uveitis: a review].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2023

Peering into the eye: A comprehensive look at ultrasound biomicroscopy (UBM) and its diagnostic value in anterior segment disorders.

Indian journal of ophthalmology
2024

Uveitis in the Setting of Co-Existing Systemic Sarcoidosis and Multiple Sclerosis.

Ocular immunology and inflammation
2023

Frequency and Treatment Regimens of Macular Edema in 1946 Consecutive Patients with Noninfectious Uveitis at a Tertiary Ophthalmic Center in Shaanxi, China.

Ophthalmology and therapy
2023

Noninfectious Uveitis in Rheumatology: Patterns, Treatment, and Outcomes.

Cureus
2023

Clinical characteristics of intermediate uveitis in adults according to criteria of the SUN working group.

International ophthalmology
2023

Brolucizumab Intravitreal Injections for Wet Age-Related Macular Degeneration: Real-Life Study on a Cohort of Italian Patients.

Medicina (Kaunas, Lithuania)
2023

The pattern of sarcoid uveitis at a tertiary care center in Nepal.

Annals of medicine and surgery (2012)
2023

An Overview of Pediatric Uveitis.

Turkish archives of pediatrics
2024

Ocular Inflammatory Events Following COVID-19 Vaccination in the Paediatric Population: A Multinational Case Series.

Ocular immunology and inflammation
2023

Uveitis: Study of 109 cases.

Medicina clinica
2023

Presence of Choroidal Caverns in Patients with Posterior and Panuveitis.

Biomedicines
2023

Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry.

Ophthalmology and therapy
2023

The Role of the Retinal Nerve Fiber Layer Thickness on OCT in the Evaluation of Papillitis in Childhood Uveitis.

American journal of ophthalmology
2023

B-Scan Ultrasound Evaluation for Uveitis in Inflammatory Arthropathies: Systematic Review.

European journal of rheumatology
2023

Ocular Tuberculosis in Pediatrics: A Case Report.

Acta medica portuguesa
2023

Acute Uveitis Following AstraZeneca COVID-19 Vaccination.

Ocular immunology and inflammation
2023

Intraocular inflammation following COVID-19 vaccination: the clinical presentations.

International ophthalmology
2023

Correlation between Morphological Characteristics of Macular Edema and Visual Acuity in Young Patients with Idiopathic Intermediate Uveitis.

Medicina (Kaunas, Lithuania)
2023

Bilateral exudative retinal detachment, unusual pattern of uveitis with multiple sclerosis.

Journal of ophthalmic inflammation and infection
2023

Commentary: Optical coherence angiography in intermediate uveitis: What is the scope?

Indian journal of ophthalmology
2023

Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review.

Journal of the International AIDS Society
2023

Human T-cell Leukemia Virus Type 1 (HTLV-1)-induced Uveitis.

Ocular immunology and inflammation
2024

Retinal Vasculitis Associated with SAPHO Syndrome Responding to Treatment with Adalimumab.

Ocular immunology and inflammation
2022

Trapped pearls in the eye.

Oman journal of ophthalmology
2023

Pattern of Uveitis at a Tertiary Eye Hospital in Eastern Province of Saudi Arabia and Comparison with Local Literature.

Ocular immunology and inflammation
2024

MEMBRANOUS ENCAPSULATION OF AN AKREOS INTRAOCULAR LENS FOLLOWING SCLERAL FIXATION MASQUERADING AS OPACIFICATION.

Retinal cases &amp; brief reports
2022

Intermediate Uveitis in Retinitis Pigmentosa Associated with a Novel Homozygous Splice Site Mutation in PRPF8.

Middle East African journal of ophthalmology
2023

Uveitis in children: Epidemiological, clinical and prognostic characteristics.

Journal francais d'ophtalmologie
2023

Commentary: Macular vessel densities in non-invasive optical coherence tomography angiography: Challenges in intermediate uveitis.

Indian journal of ophthalmology
2023

Macular vessel densities by optical coherence tomography angiography in patients with intermediate uveitis.

Indian journal of ophthalmology
Ver todos os 321 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Uveíte intermédia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Uveíte intermédia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. The Association Between Uveitis and Optic Neuritis in Central Nervous System Demyelinating Disorders: A Multi-Institutional Cohort Study.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society· 2026· PMID 41874264mais citado
  2. Long-Term Follow Up of Presumed Trematode Induced Granulomatous Intermediate Uveitis: Predictors for Failure of Medical Treatment.
    Ocular immunology and inflammation· 2026· PMID 41869886mais citado
  3. Relapsing Intermediate Uveitis following Resolved Syphilitic Retinitis in an HIV-Positive Patient: A Case Report.
    Case reports in ophthalmology· 2026· PMID 41835310mais citado
  4. Pattern of Uveitis in a Secondary Eye Care Center at Panipat, Haryana.
    Clinical ophthalmology (Auckland, N.Z.)· 2026· PMID 41710171mais citado
  5. An Atypical Presentation of Tubulointerstitial Nephritis With Uveitis (TINU) in an Older Patient Requiring Emergency Dialysis: A Case Report.
    Clinical case reports· 2026· PMID 41659937mais citado
  6. Characteristics of Uveitis in European Tertiary Ophthalmology Centers: A Systematic Review and Meta-Analysis.
    Ocul Immunol Inflamm· 2026· PMID 41994897recente
  7. Longitudinal Follow-Up of Peripapillary Kyrieleis Plaques in a Case with Unilateral Intermediate Uveitis Related to Ocular Toxoplasmosis without a Focus of Retinochoroiditis.
    Retin Cases Brief Rep· 2026· PMID 41920690recente
  8. Integrated metagenomic sequencing and phage display-based immunoprecipitation sequencing for presumptive viral infection: a case report.
    Am J Ophthalmol Case Rep· 2026· PMID 41908297recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:279914(Orphanet)
  2. MONDO:0006806(MONDO)
  3. GARD:21065(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q8511208(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Uveíte intermédia
Compêndio · Raras BR

Uveíte intermédia

ORPHA:279914 · MONDO:0006806
Prevalência
Unknown
Herança
Not applicable
CID-10
H30.2 · Ciclite posterior
CID-11
Ensaios
2 ativos
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0042166
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades